SOLARA

Solara Active Pharma Sciences Share Price

 

 

Invest in Solara Active Pharma Sciences with 2.11X leverage

Invest with MTF

Performance

  • Low
  • ₹543
  • High
  • ₹555
  • 52 Week Low
  • ₹443
  • 52 Week High
  • ₹839
  • Open Price₹545
  • Previous Close₹550
  • Volume21,439

Investment Returns

  • Over 1 Month -10.88%
  • Over 3 Month -17.45%
  • Over 6 Month + 16.09%
  • Over 1 Year -32.4%

Smart Investing Starts Here Start SIP with Solara Active Pharma Sciences for Steady Growth!

Invest Now

Solara Active Pharma Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 381.7
  • PEG Ratio
  • 3.8
  • Market Cap Cr
  • 2,447
  • P/B Ratio
  • Average True Range
  • 22.27
  • EPS
  • 1.77
  • Dividend Yield
  • 0
  • MACD Signal
  • -17.18
  • RSI
  • 47.48
  • MFI
  • 70.85

Solara Active Pharma Sciences Financials

Solara Active Pharma Sciences Technicals

EMA & SMA

Current Price
₹550.00
-0.05 (-0.01%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹549.11
  • 50 Day
  • ₹574.90
  • 100 Day
  • ₹587.67
  • 200 Day
  • ₹589.06

Resistance and Support

550.15 Pivot Speed
  • R3 579.50
  • R2 569.75
  • R1 559.90
  • S1 540.30
  • S2 530.55
  • S3 520.70

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Solara Active Pharma Sciences Ltd. is a leading pharmaceutical company in India, specializing in the production of active pharmaceutical ingredients (APIs) and intermediates. The company focuses on innovation, quality, and sustainability, catering to various therapeutic segments in the global market.

Solara Active Pharma Scis has an operating revenue of Rs. 1,206.01 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 0% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 24 which is a POOR score indicating inconsistency in earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 66 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Solara Active Pharma Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-05 Quarterly Results
2025-07-25 Quarterly Results
2025-05-15 Audited Results
2025-04-02 Others Inter-alia, to consider 1. The First Call money Notice, on the partly paid Equity Shares issued on Rights basis which is to be sent to the eligible Shareholders . to consider 1. Proposal of making First Call on 1,19,98,755 partly paid-up Equity Shares, face value of Rs.10/- each issued by the Company on rights basis. 2. Other business matters.
2025-03-26 Rights Issue & Others Rs.0.00 to consider 1. Proposal of making First Call on 1,19,98,755 partly paid-up Equity Shares, face value of Rs.10/- each issued by the Company on rights basis. 2. Other business matters.

Solara Active Pharma Sciences F&O

Solara Active Pharma Sciences Shareholding Pattern

42.01%
1.18%
13.58%
0.03%
24.02%
19.18%

About Solara Active Pharma Sciences

  • NSE Symbol
  • SOLARA
  • BSE Symbol
  • 541540
  • Managing Director & CEO
  • Mr. Sandeep Shashikantha Rao
  • ISIN
  • INE624Z01016

Similar Stocks to Solara Active Pharma Sciences

Solara Active Pharma Sciences FAQs

Solara Active Pharma Sciences share price is ₹550 As on 05 December, 2025 | 10:08

The Market Cap of Solara Active Pharma Sciences is ₹2446.8 Cr As on 05 December, 2025 | 10:08

The P/E ratio of Solara Active Pharma Sciences is 381.7 As on 05 December, 2025 | 10:08

The PB ratio of Solara Active Pharma Sciences is 2.2 As on 05 December, 2025 | 10:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23